Pablo Matar
Impact in
- Oncology top 5%
- HER2/EGFR in Cancer Research
- Colorectal Cancer Treatments and Studies
- Cancer Immunotherapy and Biomarkers
- Immunology top 10%
- Immunotherapy and Immune Responses
- Immune Cell Function and Interaction
Papers in
- Immunology 19
- Immunotherapy and Immune Responses 15
- Immune Cell Function and Interaction 14
- Oncology 15
- Cancer Treatment and Pharmacology 4
- HER2/EGFR in Cancer Research 3
- CAR-T cell therapy research 3
- Co-authors
- O. Graciela Scharovsky (18 shared papers)Viviana R. Rozados (14 shared papers)Silvia Gervasoni (11 shared papers)Marta Guzmán (4 shared papers)Federico Rojo (5 shared papers)Joaquı́n Arribas (4 shared papers)José Baselga (3 shared papers)María J. Rico (5 shared papers)
- Journals
- Cancer Immunology Immunotherapy (3 papers)Journal of Biomedical Science (3 papers)Clinical Cancer Research (2 papers)Journal of Clinical Oncology (2 papers)Generics and Biosimilars Initiative Journal (2 papers)
- Partner nations
- ArgentinaUnited StatesSpain
In The Last Decade
Pablo Matar
35 papers receiving 1.3k citations
Peers
Comparison fields: 5 of 85
- Oncology 673
- Immunology 413
- Cancer Research 177
- Pulmonary and Respiratory Medicine 308
- Molecular Biology 469
Countries citing papers authored by Pablo Matar
This map shows the geographic impact of Pablo Matar's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Pablo Matar with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Pablo Matar more than expected).
Fields of papers citing papers by Pablo Matar
This network shows the impact of papers produced by Pablo Matar. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Pablo Matar. The network helps show where Pablo Matar may publish in the future.
Co-authors
The 25 scholars most cited alongside Pablo Matar, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 37 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2004 | 232 | |
| 2 | ZD1839, a specific epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor, induces the formation of inactive EGFR/HER2 and EGFR/HER3 heterodimers and prevents heregulin signaling in HER2-overexpressing breast cancer cells. | 2003 | 213 |
| 3 | 2007 | 182 | |
| 4 | 2002 | 98 | |
| 5 | 2009 | 55 | |
| 6 | 2004 | 43 | |
| 7 | 2001 | 43 | |
| 8 | 1999 | 42 | |
| 9 | 2003 | 41 | |
| 10 | 1998 | 41 | |
| 11 | 2000 | 39 | |
| 12 | 2000 | 34 | |
| 13 | 2009 | 29 | |
| 14 | 2009 | 27 | |
| 15 | 2011 | 26 | |
| 16 | 2002 | 26 | |
| 17 | 2012 | 23 | |
| 18 | 2009 | 22 | |
| 19 | 2015 | 22 | |
| 20 | 2004 | 15 |
About Pablo Matar
Pablo Matar is a scholar working on Immunology, Oncology, Molecular Biology, Cancer Research and Hematology, having authored 37 papers that have together received 1.3k indexed citations. Recurring topics across this work include Immunotherapy and Immune Responses (15 papers), Immune Cell Function and Interaction (14 papers), Hematopoietic Stem Cell Transplantation (5 papers), Cancer Treatment and Pharmacology (4 papers), Cancer, Lipids, and Metabolism (4 papers), Lung Cancer Treatments and Mutations (4 papers), HER2/EGFR in Cancer Research (3 papers) and CAR-T cell therapy research (3 papers). The work is most often cited by research in Oncology (673 citations), Immunology (413 citations), Cancer Research (177 citations), Pulmonary and Respiratory Medicine (308 citations) and Molecular Biology (469 citations). Pablo Matar has collaborated with scholars based in Argentina, United States and Spain. Frequent co-authors include O. Graciela Scharovsky, Viviana R. Rozados, Silvia Gervasoni, Marta Guzmán, Federico Rojo, Joaquı́n Arribas, José Baselga, María J. Rico, Mariano F. Zacarías Fluck and Gabriel A. Rabinovich. Their work appears in journals such as Cancer Immunology Immunotherapy, Journal of Biomedical Science, Clinical Cancer Research, Journal of Clinical Oncology and Generics and Biosimilars Initiative Journal.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.